Real-World safety and effectiveness of evolocumab in primary hypercholesterolemia and mixed dyslipidemia in Saudi Arabia

Real-World safety and effectiveness of evolocumab in primary hypercholesterolemia and mixed dyslipidemia in Saudi Arabia

Introduction: Evolocumab’s short-term efficacy and safety were proven in phase-3 clinical trial, but its long-term safety and effectiveness in the Saudi population are yet to be studied. The aim of this study was to assess the long-term safety and effectiveness of evolocumab in Saudi patients with p...

Full description

Bibliographic Details
Main Authors: Abdulaali R. Almutairi, Walaa A. Alshahrani, Ghaida K. Alhathlol, Fatimah Alsheikh, Abdulaziz Alakeel, Majed S. Al Yami, Mohammad Fouda, Omar A. Almohammed, Meshal S. Alhamed, Awatif Hafiz, Hussam Kutbi, Alaa Bagalagel, Aisha Alharbi, Mashael Alaboud, Sarah Aljohani, Waddah Ashram
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Saudi Pharmaceutical Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016424002548

Internet

http://www.sciencedirect.com/science/article/pii/S1319016424002548

Similar Items